Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging.

Xing Z, Wang J, Ke H, Zhao B, Yue X, Dai Z, Liu J.

Nanotechnology. 2010 Apr 9;21(14):145607. doi: 10.1088/0957-4484/21/14/145607. Epub 2010 Mar 11.

PMID:
20220227
2.

Novel ultrasound contrast agent based on microbubbles generated from surfactant mixtures of Span 60 and polyoxyethylene 40 stearate.

Xing Z, Ke H, Wang J, Zhao B, Yue X, Dai Z, Liu J.

Acta Biomater. 2010 Sep;6(9):3542-9. doi: 10.1016/j.actbio.2010.03.007. Epub 2010 Mar 10.

PMID:
20226284
3.

Perfluoropropane-filled, sorbitan monostearate– and polyoxyethylene 40 stearate–shelled nanobubbles.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 2 [updated 2010 Sep 1].

4.

Nanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor.

Yang H, Cai W, Xu L, Lv X, Qiao Y, Li P, Wu H, Yang Y, Zhang L, Duan Y.

Biomaterials. 2015 Jan;37:279-88. doi: 10.1016/j.biomaterials.2014.10.013. Epub 2014 Oct 30.

PMID:
25453958
5.

Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging.

Wheatley MA, Forsberg F, Dube N, Patel M, Oeffinger BE.

Ultrasound Med Biol. 2006 Jan;32(1):83-93.

PMID:
16364800
6.

The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging.

Cai WB, Yang HL, Zhang J, Yin JK, Yang YL, Yuan LJ, Zhang L, Duan YY.

Sci Rep. 2015 Sep 3;5:13725. doi: 10.1038/srep13725.

7.

Cyanine 5.5 conjugated nanobubbles as a tumor selective contrast agent for dual ultrasound-fluorescence imaging in a mouse model.

Mai L, Yao A, Li J, Wei Q, Yuchi M, He X, Ding M, Zhou Q.

PLoS One. 2013 Apr 18;8(4):e61224. doi: 10.1371/journal.pone.0061224. Print 2013.

8.

Nanobubbles for enhanced ultrasound imaging of tumors.

Yin T, Wang P, Zheng R, Zheng B, Cheng D, Zhang X, Shuai X.

Int J Nanomedicine. 2012;7:895-904. doi: 10.2147/IJN.S28830. Epub 2012 Feb 22.

9.

Microbubble size isolation by differential centrifugation.

Feshitan JA, Chen CC, Kwan JJ, Borden MA.

J Colloid Interface Sci. 2009 Jan 15;329(2):316-24. doi: 10.1016/j.jcis.2008.09.066. Epub 2008 Oct 1.

PMID:
18950786
10.

Development and characterization of a nano-scale contrast agent.

Oeffinger BE, Wheatley MA.

Ultrasonics. 2004 Apr;42(1-9):343-7.

PMID:
15047309
11.

Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.

Wu H, Rognin NG, Krupka TM, Solorio L, Yoshiara H, Guenette G, Sanders C, Kamiyama N, Exner AA.

Ultrasound Med Biol. 2013 Nov;39(11):2137-46. doi: 10.1016/j.ultrasmedbio.2013.05.007. Epub 2013 Aug 9.

12.

Acoustic backscatter properties of the particle/bubble ultrasound contrast agent.

Phillips D, Chen X, Baggs R, Rubens D, Violante M, Parker KJ.

Ultrasonics. 1998 Jul;36(8):883-92.

PMID:
9695767
13.

Experimental investigation of the penetration of ultrasound nanobubbles in a gastric cancer xenograft.

Fan X, Wang L, Guo Y, Tong H, Li L, Ding J, Huang H.

Nanotechnology. 2013 Aug 16;24(32):325102.

PMID:
23868030
14.

A Novel Approach to Making the Gas-Filled Liposome Real: Based on the Interaction of Lipid with Free Nanobubble within the Solution.

Tian J, Yang F, Cui H, Zhou Y, Ruan X, Gu N.

ACS Appl Mater Interfaces. 2015 Dec 9;7(48):26579-84. doi: 10.1021/acsami.5b07778. Epub 2015 Nov 24.

PMID:
26567461
15.

Preparation and in vitro characterization of chitosan nanobubbles as theranostic agents.

Cavalli R, Argenziano M, Vigna E, Giustetto P, Torres E, Aime S, Terreno E.

Colloids Surf B Biointerfaces. 2015 May 1;129:39-46. doi: 10.1016/j.colsurfb.2015.03.023. Epub 2015 Mar 14.

16.

X-ray spatial frequency heterodyne imaging of protein-based nanobubble contrast agents.

Rand D, Uchida M, Douglas T, Rose-Petruck C.

Opt Express. 2014 Sep 22;22(19):23290-8. doi: 10.1364/OE.22.023290.

17.

[Preparation and evaluation of microbubble ultrasound contrast agent with N-carboxymethyl chitosan].

Lü F, Chen SX, Liu TJ, Sun HF.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Aug;28(4):497-501. Chinese.

18.

Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.

Rapoport N, Gao Z, Kennedy A.

J Natl Cancer Inst. 2007 Jul 18;99(14):1095-106. Epub 2007 Jul 10.

PMID:
17623798
19.

Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging.

Xu JS, Huang J, Qin R, Hinkle GH, Povoski SP, Martin EW, Xu RX.

Biomaterials. 2010 Mar;31(7):1716-22. doi: 10.1016/j.biomaterials.2009.11.052. Epub 2009 Dec 16.

PMID:
20006382
20.

Development of fluorous lipid-based nanobubbles for efficiently containing perfluoropropane.

Oda Y, Suzuki R, Mori T, Takahashi H, Natsugari H, Omata D, Unga J, Uruga H, Sugii M, Kawakami S, Higuchi Y, Yamashita F, Hashida M, Maruyama K.

Int J Pharm. 2015 Jun 20;487(1-2):64-71. doi: 10.1016/j.ijpharm.2015.03.073. Epub 2015 Apr 1.

PMID:
25841568

Supplemental Content

Support Center